“…It is noteworthy that one compound, a benzotriazole analog (compound VIII, Table 8), also enhanced mGlu3 receptor activity with a potency only a 5-fold weaker than that at the mGlu2 receptor. Moreover, replacement of the phenyltetrazol by a thiopyridyl or a phenylpropanoic acid end group resulted in compounds with improved brain penetration (Pinkerton et al, 2004a;Cube et al, 2005). Another lead structure emerging from this HTS was a phenyltetrazolindanone (rather than -acetophenone) compound .…”